Evidence map›Paper›PMID 42290239›Full record

ArticleDiagnostic cytopathology2026

Histopathological Correlation and Determination of Malignancy Risk in Reporting Parotid Gland Masses According to the Milan System.

Ahmet Adnan Cırık, Seyma Akgun Bostanci, Yasar Kemal Duymaz, Onur Sahin

Abstract read
In one paragraph

Article in Diagnostic cytopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ahmet Adnan CırıkDepartment of Otorhinolaryngology, Umraniye Training and Research Hospital, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-9508-0469
Seyma Akgun BostanciDepartment of Otorhinolaryngology, Umraniye Training and Research Hospital, Istanbul, Turkey.
Yasar Kemal DuymazDepartment of Otorhinolaryngology, Sultan Abdulhamidhan Training and Research Hospital, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-4887-4677
Onur SahinDepartment of Pathology, Umraniye Training and Research Hospital, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-3099-5307

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) provides a standardized framework for interpreting salivary gland fine-needle aspiration cytology (FNAC) samples and estimating the associated risk of malignancy (ROM). This study aimed to retrospectively reclassify parotid gland fine-needle aspiration (FNA) samples from our institution according to the MSRSGC, evaluate the correlation between preoperative cytological and postoperative histopathological findings, and determine the ROM for each diagnostic category. MATERIALS AND

methodsA total of 277 parotid gland FNAC cases with subsequent surgical excision between 2010 and 2024 were included. Cytological smears were independently reviewed and reclassified according to MSRSGC by two blinded pathologists. Cytology-histology concordance was assessed, and diagnostic performance metrics, including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy, were calculated. ROM for each Milan category was derived from the final histopathology.

resultsOf the 612 patients who underwent FNAC, 277 (45.3%) had available histopathological follow-up. The mean age was 49.6 ± 15.67 years, with a male-to-female ratio of 1.2:1. Benign neoplasm (Category IVa) was the most frequent cytological diagnosis (71.1%). Histopathology revealed 235 benign and 42 malignant lesions. FNAC demonstrated a sensitivity of 85.2%, specificity of 99%, PPV of 92%, NPV of 98%, and an overall diagnostic accuracy of 97.4%. ROM values were 16% for nondiagnostic, 20% for nonneoplastic, 11% for atypia of undetermined significance (AUS), 1.5% for benign neoplasm, 47% for salivary gland neoplasm of uncertain malignant potential (SUMP), 100% for suspicious for malignancy (SFM), and 90% for malignant cases. False-negative results were primarily associated with lymphoma, acinic cell carcinoma, and secretory carcinoma. The combined ROM for indeterminate categories (AUS, SUMP, and SFM) was 46%.

conclusionFNAC is a highly accurate and minimally invasive diagnostic method for parotid gland lesions. The Milan System offers valuable guidance for risk stratification and clinical management, although indeterminate categories continue to pose diagnostic difficulties. Multidisciplinary assessment and larger multicenter studies are needed to improve diagnostic precision.

Indexed as

Parotid GlandParotid NeoplasmsAdolescentAdultAgedAged, 80 and overBiopsy, Fine-NeedleFemaleHumansMaleMiddle AgedRetrospective StudiesSensitivity and SpecificityYoung Adult

Identifiers

PMID42290239
PMCPMC13428470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.